Who owns SILENCE THERAPEUTICS PLC?
- Ticker: SLN
- CUSIP Number: 82686q101
Tip: Access positions for across all investors
Analyze quarterly positions in Silence Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Silence Therapeutics stock
Who bought or sold SILENCE THERAPEUTICS PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Siren | 3.3M | $36M | 14% | Jun 2026 |
|
| TCG Crossover Management | 3.0M | $33M | 0% | Jun 2026 |
|
| Redmile Group | 2.2M | $24M | 0% | Jun 2026 |
|
| Nantahala Capital Management | 1.3M | $15M | -37% | Jun 2026 |
|
| Citadel Advisors | 1.3M | $15M | 7% | Jun 2026 |
|
| Polygon Management | 1.1M | $12M | 69% | Jun 2026 |
|
| Nextech Invest | 952k | $11M | 0% | Jun 2026 |
|
| Millennium Management | 909k | $10M | -15% | Jun 2026 |
|
| Ikarian Capital | 831k | $1.8M | -4% | Jun 2026 |
|
| Soleus Capital Management | 630k | $6.9M | 100% | Jun 2026 |
|
| Balyasny Asset Management | 611k | $6.7M | 100% | Jun 2026 |
|
| 5AM Venture Management | 476k | $5.2M | 0% | Jun 2026 |
|
| Caption Management | 460k | $5.1M | 100% | Jun 2026 |
|
| Dr. Jeffrey R. Jay, M.D. | 450k | $4.9M | -56% | Jun 2026 |
|
| Jane Street | 388k | $4.3M | 284% | Jun 2026 |
|
| Ameriprise Financial | 370k | $4.1M | 100% | Jun 2026 |
|
| ADAR1 Capital Management | 338k | $3.7M | 97% | Jun 2026 |
|
| SummitTX Capital | 327k | $3.6M | 100% | Jun 2026 |
|
| Schonfeld Strategic Advisors | 269k | $3.0M | 100% | Jun 2026 |
|
| UBS Group | 243k | $2.7M | -2% | Jun 2026 |
|
| Susquehanna International | 234k | $2.6M | 51% | Jun 2026 |
|
| BlackRock | 220k | $2.4M | 7% | Jun 2026 |
|
| Bank Of Montreal | 203k | $1.1M | 100% | Mar 2026 |
|
| Boothbay Fund Management | 198k | $2.2M | -5% | Jun 2026 |
|
| Propel Bio Management | 192k | $2.1M | 100% | Jun 2026 |
|
| Fred Alger Management | 177k | $1.9M | 100% | Jun 2026 |
|
| Qube Research & Technologies | 164k | $1.8M | 57% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 159k | $1.7M | 8% | Jun 2026 |
|
| Goldman Sachs Group | 156k | $1.7M | 197% | Jun 2026 |
|
| Hsbc Holdings | 123k | $1.3M | 0% | Jun 2026 |
|
| Two Sigma Investments | 121k | $1.3M | 647% | Jun 2026 |
|
| Quadrature Capital | 118k | $1.3M | 100% | Jun 2026 |
|
| Squarepoint Ops | 116k | $1.3M | 30% | Jun 2026 |
|
| XTX Topco | 108k | $1.2M | 1% | Jun 2026 |
|
| M28 Capital Management | 101k | $1.1M | 0% | Jun 2026 |
|
| Marshall Wace | 72k | $791k | -58% | Jun 2026 |
|
| Birchview Capital | 71k | $782k | 100% | Jun 2026 |
|
| Morgan Stanley | 66k | $345k | -80% | Mar 2026 |
|
| Seven Fleet Capital Management | 60k | $660k | -62% | Jun 2026 |
|
| Hrt Financial | 31k | $337k | 156% | Jun 2026 |
|
| Geode Capital Management | 30k | $324k | 0% | Jun 2026 |
|
| Virtu Financial | 26k | $282k | 100% | Jun 2026 |
|
| Bank of America Corporation | 25k | $278k | -15% | Jun 2026 |
|
| Trexquant Investment | 24k | $262k | 100% | Jun 2026 |
|
| Verdad Advisers | 20k | $224k | 100% | Jun 2026 |
|
| Scientech Research | 19k | $210k | 100% | Jun 2026 |
|
| Renaissance Technologies | 17k | $186k | 100% | Jun 2026 |
|
| Arrowpoint Investment Partners | 16k | $179k | 100% | Jun 2026 |
|
| Persistent Asset Partners | 15k | $167k | 100% | Jun 2026 |
|
| Raymond James Financial | 15k | $165k | -40% | Jun 2026 |
|
| Rhumbline Advisers | 14k | $152k | -1% | Jun 2026 |
|
| Axq Capital | 13k | $138k | 100% | Jun 2026 |
|
| SG Americas Securities | 12k | $132k | -96% | Jun 2026 |
|
| Acadian Asset Management | 12k | $129k | 146% | Jun 2026 |
|
| GAMMA Investing | 11k | $122k | 18% | Jun 2026 |
|
| CenterBook Partners | 10k | $114k | 100% | Jun 2026 |
|
| China Universal Asset Management | 7.5k | $82k | -10% | Jun 2026 |
|
| Jpmorgan Chase & Co | 3.9k | $42k | 100% | Jun 2026 |
|
| Barclays | 3.4k | $38k | 16% | Jun 2026 |
|
| Jones Financial Companies, L.L | 2.5k | $25k | 0% | Jun 2026 |
|
| Mirae Asset Global Investments | 2.5k | $13k | 7% | Mar 2026 |
|
| Citigroup | 1.8k | $9.7k | 100% | Mar 2026 |
|
| Tower Research Capital | 1.6k | $18k | -29% | Jun 2026 |
|
| Parallel Advisors | 1.3k | $14k | 0% | Jun 2026 |
|
| Rialto Wealth Management | 1.0k | $11k | 100% | Jun 2026 |
|
| Gf Fund Management | 975.00 | $11k | -7% | Jun 2026 |
|
| Steward Partners Investment Advisory | 100.00 | $1.1k | 0% | Jun 2026 |
|
| Rockefeller Capital Management | 45.00 | $494.001000 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 41.00 | $449.999600 | 1267% | Jun 2026 |
|
| SBI Securities | 28.00 | $307.000400 | 0% | Jun 2026 |
|
| Royal Bank of Canada | 26.00 | $0 | 62% | Jun 2026 |
|
Who sold out of Silence Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jones Hill Capital | Mar 2026 | 302k | $1.6M |
| Point72 Asset Management | Mar 2026 | 120k | $631k |
| Dynamic Technology Lab Private | Mar 2026 | 11k | $55k |
| Global Retirement Partners | Dec 2025 | 1.0k | $6.1k |
| Simplex Trading | Mar 2026 | 612.00 | $3.2k |